Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for Pleural mesothelioma, drawn from the whole corpus: 9 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
No curative treatment for the majority; median survival with the best regimens is about 18 months.
Sarcomatoid disease responds poorly to everything except immunotherapy.
No screening test for exposed workers, though BAP1 germline carriers and asbestos cohorts are being followed.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 10 changes by month →When this page itself was last checked or edited.
OS HR 1.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
OS 17.
OS 18.